Aim Bulletin

Aptamer Group inks Optimer licensing agreement with Alphazyme

By Iain Gilbert

Date: Tuesday 23 Dec 2025

(Sharecast News) - Synthetic binders developer Aptamer Group has signed a licensing agreement with Alphazyme for the use of an Optimer binder in hot‑start PCR applications.
Under the deal, Aptamer will grant Alphazyme a non‑exclusive licence to use the enzyme‑modulating Optimer across its hot‑start PCR and NGS products and services. Alphazyme...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page